Use of goal attainment scaling to measure treatment effects in an anti-dementia drug trial

Neuroepidemiology

Volumn 15, Issue 6, 1996, Pages 330-338

  Rockwood, Kenneth ^a   Stolee, Paul ^b   Howard, Kellee ^a   Mallery, Laurie ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Clinical trials; Dementia; Goal attainment scaling; Measurement

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MEASUREMENT; MULTICENTER STUDY; TREATMENT OUTCOME;

EID: 0029858790     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000109923     Document Type: Article

References (28)

1. Jarvick LF. Berg I, Bartus R, et al: Clinical drug trials in Alzheimer disease. What arc some of the issues? Alzheimer Dis Assoc Disord 1990;4: 193-202.
2. Rockwood K: Use of global assessment measures in dementia drug trials. J Clin Epidemiol I994;47: 101-103.
3. Sano M, Maycux R: Clinical assessment of efficacy for drug trials in memory disorders; in Canal N, Ha-chinski VC, McKhann G, Franceshi M (cds): Guidelines of Drug Trials in Memory Disorders. New York, Raven Press. 1993.
4. Wilcock GK: End points, duration and side-effects; in Canal N, Ha-chinski VC, McKann G, Franceshi M (cds): Guidelines of Drug Trials in Memory Disorders. New York, Raven Press, 1993.
5. Guyatt G, Walter S, Norman G: Measuring change over time: Assessing the usefulness of evaluative instruments. J Chron Disord 1987; 40:171-180.
6. Streiner DL, Norman GR: Health Measurement Scales: A Practical Guide to Their Development and Use. New York/Oxford. Oxford University Press, 1989.
7. Schneider LS, Olin JT: Overview of clinical trials ofhydcrgine in dementia. Arch Neurol 1994;51:787-798.
8. Knopman DS, Knapp MJ, Gracon SI, Davis CS: The clinician interview based impression: A clinician’s global change rating scale in Alzheimer’s disease. Neurology 1994; 44:2315-2321.
9. Kircsuk TJ, Sherman RE: Goal Attainment Scaling: A general method for evaluating comprehensive community mental health programs. Community Ment Health J 1968;4: 443-453.
10. Rockwood K, Stolee P, Fox RA: The use of Goal Attainment Scaling in measuring clinically important change in the frail elderly. J Clin Epidemiol 1993;46:1113-1118.
11. Stolee P, Rockwood K, Fox RA, Streiner DL: The use of Goal Attainment Scaling in a geriatric care setting. J Am Geriatr Soc 1992,40: 574-578.
12. Tugwcll P, Bombardier C. Bell M, Bennett K, Benscn W, Grace E, Hart L, Goldsmith C: Current quality of life research challenges in arthritis relevant to the issue of clinical significance. Control Clin Trials 1991; 12:217S-225S.
13. Maleo JF, Smigielski JS, Dc Pompo-lo RW: Goal Attainment Scaling and outcome measurement in post acute brain injury rehabilitation. Arch Phys Med Rehabil 1991;72: 138-143.
14. Joyce B, Rockwood K, Mate-Cole C: Use of Goal Attainment Scaling in traumatic brain injury at a rehabilitation hospital. Am J Phys Med Rc-habil 1994;73:10-14.
15. Folstcin MF, Folstein SE, McHugh PR: 'Mini-Mental State’: A practical method for grading the cognitive slate of patients for the clinician. J Psychiatry Res 1975;12:189-198.
16. Mohrs RC. Rosen WG, Davis KL: The Alzheimer's Disease Assessment Scale: An instrument for assessing treatment efficacy. Psycho-pharmacol Bull 1983;19:448-450.
17. Lawton MP, Brody EM: Assessment of older people: Self maintaining and instrumental activities of daily living. Gerontologist 1969:9:179-186.
18. Reisberg B, Ferris SH: Brief Cognitive Rating Scale (BCRS). Psycho-pharmacol Bull 1988;24:629-636.
19. Reisberg B, Ferris SH, de Leon MJ, et al: The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
20. Rockwood K: Sett ing goals in geriatric rehabilitation and measuring their attainment. Rev Clin Gerontol 1994;4:141-149.
21. Kracmcr HC, Thieman S: How Many Subjects? Statistical Power Analysis in Research. Newbury Park, Sage. 1987.
22. Liang MH, Larson MG, Cullen KE, et al: Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1987; 28:542-547.
23. Anderson JJ. Firschcin HE, Mcc-nan RF: Sensitivity of a health status measure to short-term clinical changes in arthritis. Arthritis Rheum 1989;32:844-849.
24. Kazis LE, Anderson JJ, Mccnan RF: Effect sizes for interpreting changes in health status. Med Care 1989;27: 178-189.
25. Analytical Software, Inc. Statistix, version 4 St. Paul, MN: Analytical Software, Inc. 1994.
26. Glaser BG, Strauss AL: Discovery of Grounded Theory: Strategics for Qualitative Research. Chicago, Aldine, 1967.
27. Foretto F, Bert P, Breuil V, Boiler F: Therapeutic drug trials and heterogeneity of Alzheimer’s disease; in Boiler F, Forcttc F, Khachaturian Z, Poncet M, Christen Y (eds): Heterogeneity of Alzheimer’s Disease. New York. Springer, 1992.
28. Grafman J: Heterogeneous disappearance of knowledge in Alzheimer’s disease; in Boiler F. Forette F, Khachaturian Z, Poncet M, Christen Y (eds): Heterogeneity of Alzheimer Disease. New York, Springer, 1992.